News

Filter

Current filters:

zoledronic acid

1 to 9 of 85 results

Denosumab superior to zoledronic acid for breast cancer patients with bone metastases

15-08-2012

Treatment with denosumab resulted in a greater reduction in skeletal-related events in patients with…

AmgenBiotechnologydenosumabNovartisOncologyPharmaceuticalProliaReclastResearchXgevazoledronic acid

Bone drug zoledronic acid may help prevent spread of early lung cancer

02-03-2011

Zoledronic acid, a drug that is currently used to help treat bone metastases in patients with lung cancer…

NovartisOncologyPharmaceuticalReclastResearchzoledronic acid

Novartis once-yearly Reclast preserves bone mass, provides fracture protection in postmenopausal osteoporosis, long term data show

18-10-2010

Swiss drug major Novartis (NOVN.VX) presented new six-year data reinforcing the long-term efficacy and…

Anti-Arthritics/RheumaticsNovartisPharmaceuticalReclastResearchzoledronic acid

Analysts see positive future for Amgen’s bone metastases drug denosumab following strong Ph III data

10-02-2010

US biotechnology major Amgen received a boost recently when the company announced positive results from…

AmgenAnti-Arthritics/RheumaticsFinancialNovartisOncologyPharmaceuticalzoledronic acidZometa

1 to 9 of 85 results

COMPANY SPOTLIGHT

Menarini

Back to top